Obstetrics (HIV Vertical Transmission)

Prenatal ZDV Reduces Risk of Maternal HIV Transmission

Published in Women's Health Weekly, June 3rd, 1996

Prenatal treatment with zidovudine (ZDV) has shown to be a significant factor in reducing the chances of HIV infection being transmitted from HIV positive mothers to their babies.

Marilyn M. Doyle, M.D., University of Texas-Houston Health Science Center researcher, studied the maternal medical records of 104 infants born to 103 HIV infected mothers. The study focused on the use of ZDV in prenatal care. Doyle presented her findings at the annual meeting of the American Pediatric Society/Society for Pediatric Research, held in Washington, D.C., May 6-10, 1996.

Of the 103 study subjects, 51 (50 percent) of the mothers took prenatal ZDV, 44 (43...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (1996-06-03)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry